Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases.
Parakh, Sagun; Park, John J; Mendis, Shehara; Rai, Rajat; Xu, Wen; Lo, Serigne; Drummond, Martin; Rowe, Catherine; Wong, Annie; McArthur, Grant; Haydon, Andrew; Andrews, Miles C; Cebon, Jonathan; Guminski, Alex; Kefford, Richard F; Long, Georgina V; Menzies, Alexander M; Klein, Oliver; Carlino, Matteo S.
Br J Cancer
; 116(12): 1558-1563, 2017 Jun 06.
Artigo em Inglês | MEDLINE | ID: mdl-28524161
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.
Changing Treatment Paradigms for Brain Metastases From Melanoma-Part 1: Diagnosis, Prognosis, Symptom Control, and Local Treatment.
Treatment of melanoma brain metastases.
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab.
Treatment of Melanoma CNS Metastases.
Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy.
Clinical parameters associated with anti-programmed death-1 (PD-1) inhibitors-induced tumor response in melanoma patients.
Immunotherapy for Melanoma.
Primary cerebral malignant melanoma in insular region with extracranial metastasis: case report and review literature.
Immunotherapy Plus Stereotactic Radiosurgery: Building on the Promise of Precision Medicine for CNS Malignancies-PART 2: Existing Experience and Considerations for Future Trials.